Private Label Peptides: Labeling, MOQ, and SKU Planning for Brands
A private label peptide line runs on three planning tracks: label copy that carries the full Research Use Only language, SKU planning mapped to existing formats and categories, and minimum order quantities driven mainly by packaging complexity rather than by the compound. Get compliance review on artwork before print, not after.
What Private Label Actually Means Here
Private label in this category means your brand on existing catalog formats and categories. It generally does not mean new compound development, and any supplier promising a proprietary formulation as a starting point is describing something with a much longer timeline and a much different cost structure than they are probably implying.
That is not a limitation so much as a clarification. The value of a private label peptide program is brand control, margin, and account ownership. It is not chemistry.
Label Copy Is the Part That Sinks Launches
Every compliance obligation that applies to a house-brand product applies to yours. The Research Use Only and Not For Human Consumption language is not negotiable based on how the brand is positioned, and it is not something to shrink into six-point type at the bottom of the panel.
More importantly, your label and your marketing are now part of the objective intent picture. FDA reads intended use from everything a seller publishes. If your packaging is compliant and your Instagram is not, the packaging does not save you.
What Belongs on Private Label Peptide Packaging
- Product identity and, where applicable, sequence or compound designation
- Strength and net quantity, stated unambiguously
- Lot number, carried forward from the manufacturing lot
- Storage conditions per the SKU specification
- Research Use Only — Not For Human Consumption, prominently placed
- Your entity name and contact information as the responsible party
- Any format-specific handling or hazard language drawn from the Safety Data Sheet
What Must Not Appear on Private Label Peptide Packaging
- Any condition, symptom, outcome, or physiological effect
- Dosing, administration, reconstitution, or usage instructions
- Comparison to any approved prescription drug, by name or by implication
- Imagery implying human or clinical use
- Unqualified country-of-origin claims that your documentation cannot support
Sequence This Correctly
Compliance review on label artwork happens before print, not after. A relabeling cycle on a completed print run is expensive, slow, and entirely avoidable. Build the review step into your project timeline as a gate, not as a courtesy check at the end.
MOQ: What Actually Drives It
Buyers usually assume minimum order quantity is a function of the compound. It is mostly a function of packaging.
- Custom label printing. Print runs have their own economics. A custom label is generally the largest single MOQ driver.
- Format complexity. A capsule bottle, a vial with a crimped seal, and a spray bottle with a pump assembly have different component supply chains and different minimums.
- Secondary packaging. Cartons, inserts, and tamper-evident features each add their own minimum.
- SKU count. Ten SKUs at low volume each is a harder program to run than three SKUs at higher volume, and it prices that way.
- Compound and strength. Real, but usually the smallest factor of the five.
The practical implication is that narrowing your launch SKU list is the most effective lever you have on program economics. Brands that launch with a focused range and expand later almost always do better than brands that launch wide.
Private Label by Starting Point
1. Compound.
Which compounds the line will carry.
2. Format.
Vial, nasal spray, oral spray, capsule. Each is a separate SKU with separatepackaging and separate storage requirements.
3. Strength or fill.
fill. Multiple strengths of the same compound in the same format are separate SKUs and need separate label artwork.
Four compounds, two formats, two strengths is sixteen SKUs, sixteen artwork files, and sixteen MOQs. That arithmetic surprises people, and it is worth doing on paper before the design brief goes out.
Build your internal SKU codes to encode format and strength from the start. Retrofitting a naming scheme after launch, when inventory and documentation are already tied to the old codes, is genuinely painful.
Realistic Launch Sequence
1. Qualification.
Wholesale account approval and buyer verification complete before anything else starts.
2. Range definition.
Compounds, formats, strengths. Lock the SKU count here.
3. MOQ and pricing confirmation.
Per format, per SKU, before packaging design begins.
4. Label copy draft.
Compliance content first, brand design second. It is much easier to design around required copy than to retrofit it.
5. Compliance review gate.
Artwork reviewed and signed off before any print file is released.
6. Print and production scheduling.
Artwork reviewed and signed off before any print file is released.
7. Documentation handoff.
Confirm how lot numbers and COAs flow to you and, if you resell, through you.
Private Label by Starting Point
Clinics Building an In-House Line
Start narrow. Two or three SKUs in one format is a real program; twelve SKUs across four formats is an inventory problem. Your storage capacity is usually the binding constraint, not your MOQ.
Established Supplement or Wellness Brands
Your existing marketing playbook does not transfer. Claims language that is normal in supplements is disqualifying here, and your agency will need briefing before they write a word.
Distributors Adding a House Brand
Documentation pass-through is your main design question. Decide early how lot-level COAs reach your customers under your brand.
New Entrants
Budget for compliance review as a line item and for a longer artwork cycle than you expect. The first label round rarely clears.
Private Label Peptide Planning Checklist
- Complete wholesale account qualification before starting packaging design
- Lock your compound, format, and strength matrix and count the resulting SKUs
- Confirm MOQ per format and per SKU before committing to artwork
- Draft required RUO and compliance label copy before brand design begins
- Confirm storage requirements per format and check them against your storage capacity
- Build an internal SKU naming scheme that encodes format and strength
- Schedule a compliance review gate on artwork before releasing any print file
- Confirm how lot numbers and COAs will be delivered to you and passed downstream
- Brief your marketing team or agency on claims restrictions before any copy is written
- Plan print lead time and production scheduling as separate timelines
Frequently Asked Questions
It is your brand applied to a supplier's existing catalog formats and categories, including custom label
artwork and sometimes custom secondary packaging. It generally does not involve new compound
development.
Product identity, strength and net quantity, lot number, storage conditions, your entity as responsible
party, and prominent Research Use Only — Not For Human Consumption language. Format-specific
handling language from the Safety Data Sheet may also apply.
Packaging complexity, mainly. Custom label print runs, format component supply, secondary
packaging, and the number of distinct SKUs matter more than the compound itself.
Private label programs are generally built around existing catalog formats and categories. New
compound development is a different kind of project with a different timeline, and current capabilities
should be confirmed directly.
It depends on SKU count, label design cycles, compliance review, and production scheduling. The
step most often underestimated is artwork review, because first rounds rarely clear on compliance.
It increases them. Your label and your marketing become part of the intended-use picture regulators
look at, independently of your supplier's compliance posture.
Not therapeutic, outcome, or condition claims. Research Use Only framing constrains your marketing
the same way it constrains ours, and your brand carries that obligation directly.
Yes. Once a private label formulation and packaging specification are finalized, that record stays on file so reorders can go through your account contact without repeating the full setup process.